TCL Archive Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial July 25, 2014
TCL Archive NCIs FY95 Bypass To Justify $3.47 Billion, includes $490 million For Breast Cancer Research May 14, 1993
TCL Archive DeVita Says Payline Compression Leading to More Decisions By Staff On Funding June 28, 1985
TCL Archive Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development March 15, 1991